Arterolane
Alternative Names: OZ 03; OZ277; RBx-11160; Synperoxolane; Synthetic peroxide project - MMV99/0086; Trioxolane 7Latest Information Update: 02 Oct 2021
At a glance
- Originator Medicines for Malaria Venture; Roche
- Developer Medicines for Malaria Venture; Ranbaxy Laboratories
- Class 1 ring heterocyclic compounds; Antimalarials; Peroxides; Small molecules; Spiro compounds
- Mechanism of Action Adenosine triphosphatase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Malaria
Most Recent Events
- 25 Mar 2015 Ranbaxy Laboratories has been acquired by Sun Pharmaceutical Industries
- 31 Dec 2010 Discontinued - Phase-I for Malaria in United Kingdom (PO)
- 31 Dec 2010 Discontinued - Phase-II for Malaria in India (PO)